Market Tracker

06/28 5:16pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

10.83
Delayed Data
As of 4:00pm ET
 +0.88 / +8.84%
Today’s Change
9.23
Today|||52-Week Range
56.16
-70.24%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close9.95
Today’s open10.07
Day’s range10.07 - 10.92
Volume343,487
Average volume (3 months)733,874
Market cap$287.5M
Dividend yield--
Data as of 4:00pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)-142.47%
Earnings growth (this year)-114.61%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.31%
P/E ratioNM
Price/Sales15.19
Price/Book1.46

Competitors

 Today’s
change
Today’s
% change
VSARVersartis Inc+0.35+3.56%
PGNXProgenics Pharmaceut...+0.18+4.43%
AKBAAkebia Therapeutics ...+0.43+5.94%
VTAEVitae Pharmaceutical...+0.63+6.05%
Data as of 4:00pm ET, 06/28/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$68.5M
Annual profit (last year)-$40.4M
Net profit margin-58.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts